Surrogate end points for clinical trials of kidney disease progression

被引：115

作者：

Stevens, Lesley A.

Greene, Tom

Levey, Andrew S.

机构：

[1] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA

[2] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 1卷 / 04期

关键词：

D O I：

10.2215/CJN.00600206

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：874 / 884

页数：11

共 53 条

[1]

[Anonymous], 1969, Physiology of the Human Kidney

[2] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[3] Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure [J].

Avorn, J ;

Winkelmayer, WC ;

Bohn, RL ;

Levin, R ;

Glynn, RJ ;

Levy, E ;

Owen, W .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (07) :711-716

[4] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[5]

Brenner BM, 2000, BRENNER RECTORS KIDN

[6] Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy [J].

Breyer, JA ;

Bain, RP ;

Evans, JK ;

Nahman, NS ;

Lewis, EJ ;

Cooper, M ;

McGill, J ;

Berl, T ;

Rohde, R ;

Hunsicker, LG ;

Lachin, J ;

Greenhouse, SW ;

Verme, DA ;

Turlington, TR ;

Burrows, PK ;

Wish, J ;

Sheehan, J ;

Pohl, M ;

Berl, T ;

Santiago, G ;

Hunsicker, L ;

Kern, EFO ;

Lemann, J ;

Blementhal, S ;

Bresnahan, BS ;

Hebert, L ;

Goldfarb, S ;

Kobrin, S ;

Rodby, R ;

Levey, A ;

McLaughlin, M ;

Williams, M ;

McGill, J ;

Whittler, F ;

Rutecki, G ;

Cattran, D ;

Lietz, S ;

Valaitis, D ;

Hano, J ;

Maxwell, D ;

Porush, J ;

Spitalewitz, S ;

Shapiro, K ;

Adler, S ;

Tolchin, N ;

Hoy, W ;

Bernstein, R ;

Svetkey, L ;

Sharon, Z ;

Rausenbaum, B .

KIDNEY INTERNATIONAL, 1996, 50 (05) :1651-1658

[7] The role of proteinuria in the progression of chronic renal failure [J].

Burton, C ;

Harris, KPG .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (06) :765-775

[8]

Burzykowski T., 2005, EVALUATION SURROGATE

[9]

Buyse M, 2000, Biostatistics, V1, P49, DOI 10.1093/biostatistics/1.1.49

[10]

CHAKRAVARTY AG, 2003, SURROGATE MARKERS TH

← 1 2 3 4 5 6 →